EUVIMEDAtrasti EUVIMED
MetaanalyseSystematische ÜbersichtOpen access

Effect of GLP‐1 Receptor Agonists on Post‐Ablation Atrial Fibrillation Recurrence: A Meta‑Analysis

Abdalhakim Shubietah iD, Mohamed S Elgendy iD, Ameer Awashra iD, Mohamed R Murad, Mohammad Alqudah iD, Ibrahim Gowaily, Ahmed Almahdy Mohamed, Ahmed Emara iD, Emmanuel Olumuyide, Ahmed Elbataa, Mohamed Abuelazm iD, Mohammed Mhanna iD

Pacing and Clinical Electrophysiology · 2026-08 · 49 (8) · 1086-1099

DOI: 10.1111/pace.70262 ↗

At a glance

Metaanalyse in Pacing and Clinical Electrophysiology, published online on 2026-04-25. Written by Abdalhakim Shubietah and 11 co-authors. Institution: Department of Medicine, Advocate Illinois Masonic Medical Center, Chicago, Illinois, USA. Major MEDLINE topics: Atrial Fibrillation, Catheter Ablation, Glucagon-Like Peptide-1 Receptor Agonists. Cited 5 times so far (Crossref); 37 references. The full text is freely available in PubMed Central.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Among patients undergoing catheter ablation for atrial fibrillation (AF), it remains uncertain whether peri‐ or post‐ablation use of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) reduces AF recurrence.

Objectives

We conducted a meta‐analysis of observational studies and randomized controlled trials comparing GLP‐1 RA therapy versus no GLP‐1 RA use on AF recurrence following ablation.

Methods

We systematically searched PubMed, Scopus, Web of Science, and Embase for adult randomized and observational studies. Random‐effects models generated risk ratios (RRs), and heterogeneity was assessed via I 2 . Time‐to‐event outcomes were synthesized using reconstructed individual patient data from Kaplan–Meier curves.

Results

Six studies met the inclusion criteria, with four contributing data for Kaplan–Meier curve reconstruction and five included in the hazard ratio (HR) meta‐analysis. Across four studies ( n = 695; GLP‐1 RA = 295; control = 400), pooled Kaplan–Meier curves showed a lower risk of AF recurrence with GLP‐1 RA therapy (HR 0.53, 95% confidence interval [CI]: 0.38–0.72), with a restricted mean survival time (RMST) advantage of 1.02 months. A random‐effects meta‐analysis of five studies confirmed this benefit (HR 0.78, 95% CI: 0.61–0.99; I 2 = 75%). Pairwise analyses at 12 months demonstrated fewer AF recurrences with GLP‐1 RAs (28.6% vs. 32.9%; RR 0.82, 95% CI: 0.76–0.90; I 2 = 46.9%).

Conclusion

GLP‐1 RA therapy was associated with reduced AF recurrence after ablation, but methodological limitations warrant cautious interpretation. Prospective randomized trials are needed to confirm this potential benefit.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationCatheter AblationGlucagon-Like Peptide-1 Receptor AgonistsHumansRecurrenceTreatment OutcomeRandomized Controlled Trials as Topic

Author keywords

AF recurrenceGLP‐1 receptor agonistsatrial fibrillationcatheter ablationpost‐ablation therapy

Substances

Glucagon-Like Peptide-1 Receptor Agonists

Authors and institutions

  • Department of Medicine, Advocate Illinois Masonic Medical Center, Chicago, Illinois, USA.
  • Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Department of Medicine, An-Najah National University, Nablus, Palestine.
  • Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • Faculty of Medicine, Yarmouk University, Irbid, Jordan.
  • Department of Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA.

ORCID profiles: Abdalhakim Shubietah, Mohamed S Elgendy, Ameer Awashra, Mohammad Alqudah, Ahmed Emara, Mohamed Abuelazm, Mohammed Mhanna

Cite

APA

Shubietah, A., Elgendy, M. S., Awashra, A., Murad, M. R., Alqudah, M., Gowaily, I., Mohamed, A. A., Emara, A., Olumuyide, E., Elbataa, A., Abuelazm, M., & Mhanna, M. (2026). Effect of GLP‐1 Receptor Agonists on Post‐Ablation Atrial Fibrillation Recurrence: A Meta‑Analysis. Pacing and Clinical Electrophysiology, 49(8), 1086-1099. https://doi.org/10.1111/pace.70262

Vancouver

Shubietah A, Elgendy MS, Awashra A, Murad MR, Alqudah M, Gowaily I, et al. Effect of GLP‐1 Receptor Agonists on Post‐Ablation Atrial Fibrillation Recurrence: A Meta‑Analysis. Pacing and Clinical Electrophysiology. 2026;49(8):1086-1099. doi:10.1111/pace.70262

BibTeX
@article{Shubietah2026,
  author = {Shubietah, Abdalhakim and Elgendy, Mohamed S and Awashra, Ameer and Murad, Mohamed R and Alqudah, Mohammad and Gowaily, Ibrahim and Mohamed, Ahmed Almahdy and Emara, Ahmed and Olumuyide, Emmanuel and Elbataa, Ahmed and Abuelazm, Mohamed and Mhanna, Mohammed},
  title = {Effect of GLP‐1 Receptor Agonists on Post‐Ablation Atrial Fibrillation Recurrence: A Meta‑Analysis},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  volume = {49},
  number = {8},
  pages = {1086--1099},
  doi = {10.1111/pace.70262}
}
Start for free →